{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:41:13Z","timestamp":1775666473608,"version":"3.50.1"},"reference-count":116,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Cervical cancer (CC) remains among the top causes of death for women worldwide, especially in low-income countries, where screening strategies are less widespread. Treatment strategies are mainly based on DNA-damaging agents, though resistance mechanisms still pose a substantial challenge. Among the cellular components that mediate treatment resistance, long non-coding RNAs (lncRNAs) stand out because of their broad regulatory effects. They are involved in virtually all drug resistance mechanisms, such as drug efflux, DNA repair, evasion of cell death, and aberrant epigenetic modifications. Although resistance mechanisms are fundamentally similar in most cancers, the underlying regulatory networks vary substantially. Here, we review the literature for lncRNAs involved in treatment resistance mechanisms in general, and then focus on lncRNAs that mediate resistance in CC. We found a broad area of opportunity in lncRNA research in resistant CC, as the lncRNAs involved are still to be described. These master regulators are promising candidates for response markers and therapeutic targets. May this compilation serve as the basis for further descriptions of the regulatory roles of lncRNA in CC treatment resistance.<\/jats:p>","DOI":"10.3389\/fonc.2025.1644104","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:13:11Z","timestamp":1761019991000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Long noncoding RNAs involved in therapeutic response: implications for cervical cancer drug resistance"],"prefix":"10.3389","volume":"15","author":[{"given":"Samuel","family":"Trujano-Camacho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Contreras-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Garc\u00eda-Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"S\u00e1nchez-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Olvera-Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Rodr\u00edguez-Dorantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Peralta-Zaragoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Cant\u00fa","family":"de Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"L\u00f3pez-Urrutia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"P\u00e9rez-Plasencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jncc.2024.11.006","article-title":"Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022","volume":"5","author":"Wu","year":"2025","journal-title":"J Natl Cancer Cent"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55070384","article-title":"Key molecular events in cervical cancer development","volume":"55","author":"Balasubramaniam","year":"2019","journal-title":"Medicina"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.180.6.1801621","article-title":"Diagnosis, staging, and surveillance of cervical carcinoma","volume":"180","author":"Kaur","year":"2003","journal-title":"Am J Roentgenol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100579","article-title":"Recurrent or primary metastatic cervical cancer: current and future treatments","volume":"7","author":"Gennigens","year":"2022","journal-title":"ESMO Open"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125878","article-title":"Emerging Trends in cervical cancer Treatment: Transitioning from traditional to innovative delivery strategies","volume":"681","author":"Agarwal","year":"2025","journal-title":"Int J Pharm"},{"key":"B6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","article-title":"Unveiling the mechanisms and challenges of cancer drug resistance","volume":"22","author":"Khan","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1042\/ebc20200032","article-title":"Non-coding RNA in cancer","volume":"65","author":"Yan","year":"2021","journal-title":"Essays Biochem"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.960317","article-title":"Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action","volume":"12","author":"Tilsed","year":"2022","journal-title":"Front Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12943-020-01162-0","article-title":"Long non-coding RNAs regulate drug resistance in cancer","volume":"19","author":"Liu","year":"2020","journal-title":"Mol Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/humu.24418","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"43","author":"Dean","year":"2022","journal-title":"Hum Mutat"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.011.10326","article-title":"Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology","volume":"31","author":"Xue","year":"2012","journal-title":"Chin J Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.26901","article-title":"HOTAIR enhanced paclitaxel and doxorubicin resistance in gastric cancer cells partly through inhibiting miR-217 expression","volume":"119","author":"Wang","year":"2018","journal-title":"J Cell Biochem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.02.130","article-title":"LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation","volume":"101","author":"Fang","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-014-3236-2","article-title":"Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer","volume":"290","author":"Huang","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8836078","article-title":"LncRNA MALAT1 accelerates cervical carcinoma proliferation by suppressing miR-124 expression in cervical tumor cells","volume":"2021","author":"Liang","year":"2021","journal-title":"J Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.01580-13","article-title":"Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines","volume":"34","author":"Wang","year":"2014","journal-title":"Mol Cell Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12041050","article-title":"DNA damage\/repair management in cancers","volume":"12","author":"Alhmoud","year":"2020","journal-title":"Cancers"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174363","article-title":"Apoptosis deregulation and the development of cancer multi-drug resistance","volume":"13","author":"Neophytou","year":"2021","journal-title":"Cancers"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmy022","article-title":"LncRNAs in DNA damage response and repair in cancer cells","volume":"50","author":"Su","year":"2018","journal-title":"Acta Bioch Bioph Sin"},{"key":"B21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ctrv.2011.04.015","article-title":"Defective homologous recombination in human cancers","volume":"38","author":"Cerbinskaite","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01382-y","article-title":"Long non-coding RNA ANRIL promotes homologous recombination-mediated DNA repair by maintaining ATR protein stability to enhance cancer resistance","volume":"20","author":"Liu","year":"2021","journal-title":"Mol Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s13046-023-02829-4","article-title":"ATR-binding lncRNA ScaRNA2 promotes cancer resistance through facilitating efficient DNA end resection during homologous recombination repair","volume":"42","author":"Chen","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.8186","article-title":"Long non-coding nuclear paraspeckle assembly transcript 1 acts as prognosis biomarker and increases cell growth and invasion in cervical cancer by sequestering microRNA-101","volume":"17","author":"Wang","year":"2018","journal-title":"Mol Med Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201807_15400","article-title":"LncRNA NEAT1 regulates cervical carcinoma proliferation and invasion by targeting AKT\/PI3K","volume":"22","author":"Guo","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2016.11.058","article-title":"Long non-coding RNA ANRIL indicates a poor prognosis of cervical cancer and promotes carcinogenesis via PI3K\/Akt pathways","volume":"85","author":"Zhang","year":"2017","journal-title":"BioMed Pharmacother"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1091779","article-title":"The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s12079-023-00746-x","article-title":"Emerging roles of the long non-coding RNA NEAT1 in gynecologic cancers","volume":"17","author":"Farzaneh","year":"2023","journal-title":"J Cell Commun Signal"},{"key":"B29","doi-asserted-by":"publisher","first-page":"17436","DOI":"10.1038\/s41598-025-01698-5","article-title":"LncRNA NEAT1 regulation of the miR-101-3p\/RAC1 axis affects cervical cancer aerobic glycolysis and progression","volume":"15","author":"Cao","year":"2025","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1515\/biol-2021-0104","article-title":"Clinical significance of activated Wnt\/\u03b2-catenin signaling in apoptosis inhibition of oral cancer","volume":"16","author":"Wang","year":"2021","journal-title":"Open Life Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-020-00242-3","article-title":"Functional characterization of SOX2 as an anticancer target","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3233\/cbm-181467","article-title":"Down-regulation of long non-coding RNA ANRIL inhibits the proliferation, migration and invasion of cervical cancer cells","volume":"23","author":"Zhang","year":"2018","journal-title":"Cancer biomark"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202201889","article-title":"APAF1-binding long noncoding RNA promotes tumor growth and multidrug resistance in gastric cancer by blocking apoptosome assembly","volume":"9","author":"Wang","year":"2022","journal-title":"Adv Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.703","article-title":"LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability","volume":"12","author":"Zhu","year":"2022","journal-title":"Clin Transl Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2012.13.10.4867","article-title":"Autophagy in cervical cancer: an emerging therapeutic target","volume":"13","author":"Pandey","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.297","article-title":"Autophagy promotes paclitaxel resistance of cervical cancer cells: involvement of Warburg effect activated hypoxia-induced factor 1-\u03b1-mediated signaling","volume":"5","author":"Peng","year":"2014","journal-title":"Cell Death Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.21037\/tcr.2019.11.17","article-title":"HIF2A overexpression reduces cisplatin sensitivity in cervical cancer by inducing excessive autophagy","volume":"9","author":"Jiang","year":"2019","journal-title":"Transl Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00343","article-title":"The drug-resistance mechanisms of five platinum-based antitumor agents","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Pharmacol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.molcel.2013.11.004","article-title":"Reciprocal regulation of HIF-1\u03b1 and lincRNA-p21 modulates the warburg effect","volume":"53","author":"Yang","year":"2014","journal-title":"Mol Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/cells13171484","article-title":"HOTAIR promotes the hyperactivation of PI3K\/akt and wnt\/\u03b2-catenin signaling pathways via PTEN hypermethylation in cervical cancer","volume":"13","author":"Trujano-Camacho","year":"2024","journal-title":"Cells"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01237-y","article-title":"LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt\/\u03b2-catenin and autophagy pathway through modulating the miR-619-5p\/Pygo2 and miR-619-5p\/ATG14 axes","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01299-y","article-title":"LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM","volume":"20","author":"Zhang","year":"2021","journal-title":"Mol Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2021.1901204","article-title":"(lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation","volume":"17","author":"Luo","year":"2021","journal-title":"Autophagy"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2020.06","article-title":"Epigenetic basis of cancer drug resistance","volume":"3","author":"Aziz","year":"2020","journal-title":"Cancer Drug Resist"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nature02625","article-title":"Epigenetics in human disease and prospects for epigenetic therapy","volume":"429","author":"Egger","year":"2004","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3892\/or.2012.1912","article-title":"Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells","volume":"28","author":"Masuda","year":"2012","journal-title":"Oncol Rep"},{"key":"B47","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12935-015-0248-3","article-title":"Changes in DNA methylation are associated with the development of drug resistance in cervical cancer cells","volume":"15","author":"Chen","year":"2015","journal-title":"Cancer Cell Int"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.00484-17","article-title":"MOF suppresses replication stress and contributes to resolution of stalled replication forks","volume":"38","author":"Singh","year":"2018","journal-title":"Mol Cell Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s12885-017-3430-2","article-title":"Inhibition of HDAC6 activity through interaction with RanBPM and its associated CTLH complex","volume":"17","author":"Salemi","year":"2017","journal-title":"BMC Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201695335","article-title":"PRC2 is dispensable for HOTAIR-mediated transcriptional repression","volume":"36","author":"Portoso","year":"2017","journal-title":"EMBO J"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.7150\/thno.25541","article-title":"Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19","volume":"8","author":"Ren","year":"2018","journal-title":"Theranostics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-019-0777-7","article-title":"Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer","volume":"12","author":"Xiong","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.s257311","article-title":"NEAT1 knockdown suppresses the cisplatin resistance in ovarian cancer by regulating miR-770-5p\/PARP1 axis","volume":"12","author":"Zhu","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e9234","DOI":"10.7717\/peerj.9234","article-title":"Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancer","volume":"8","author":"Wen","year":"2020","journal-title":"PeerJ"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.0027","article-title":"NCCN guidelines insights: cervical cancer, version 1.2020: featured updates to the NCCN guidelines","volume":"18","author":"Abu-Rustum","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: an overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174136","article-title":"New insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment","volume":"20","author":"Chen","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl435","article-title":"Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy","volume":"18","author":"Bellmunt","year":"2007","journal-title":"Ann Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-58","article-title":"Stabilization of mismatch repair gene PMS2 by glycogen synthase kinase 3\u03b2 is implicated in the treatment of cervical carcinoma","volume":"10","author":"Zhang","year":"2010","journal-title":"BMC Cancer"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2006.10.007","article-title":"Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance","volume":"251","author":"Brozovic","year":"2007","journal-title":"Cancer Lett"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20522","article-title":"Long-term activation of SAPK\/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance","volume":"112","author":"Brozovic","year":"2004","journal-title":"Int J Cancer"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/mc.20116","article-title":"Biological and chemical inhibitors of NF-\u03baB sensitize SiHa cells to cisplatin-induced apoptosis","volume":"44","author":"Venkatraman","year":"2005","journal-title":"Mol Carcinog"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13921","article-title":"DANCR-mediated microRNA-665 regulates proliferation and metastasis of cervical cancer through the ERK\/SMAD pathway","volume":"110","author":"Cao","year":"2019","journal-title":"Cancer Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27647","article-title":"Growth arrest-specific 5 attenuates cisplatin-induced apoptosis in cervical cancer by regulating STAT3 signaling via miR-21","volume":"234","author":"Yao","year":"2019","journal-title":"J Cell Physiol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156274","article-title":"The lncRNA PVT1 contributes to the cervical cancer phenotype and associates with poor patient prognosis","volume":"11","author":"Iden","year":"2016","journal-title":"PloS One"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2019.01.025","article-title":"Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity","volume":"696","author":"Feng","year":"2019","journal-title":"Gene"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2016.2156","article-title":"Expression of long noncoding RNA urothelial cancer associated 1 promotes cisplatin resistance in cervical cancer","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Biotherapy Radiopharm"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3724\/abbs.2025032","article-title":"Long noncoding RNA UCA1 knockdown inhibits cisplatin-resistant cervical cancer tumorigenesis via the miR-195-5p\/IKBKB axis","volume":"57","author":"Wang","year":"2025","journal-title":"Acta Biochim Biophys Sin"},{"key":"B71","article-title":"Carboplatin-docetaxel-induced activity against ovarian cancer is dependent on up-regulated lncRNA PVT1","volume":"8","author":"Liu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27403","article-title":"Long noncoding RNA SNHG12 promotes the progression of cervical cancer via modulating miR-125b\/STAT3 axis","volume":"234","author":"Jin","year":"2019","journal-title":"J Cell Physiol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2019.06.012","article-title":"Deregulation of H19 is associated with cervical carcinoma","volume":"112","author":"Roychowdhury","year":"2020","journal-title":"Genomics"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s267433","article-title":"Research status and outlook of PD-1\/PD-L1 inhibitors for cancer therapy","volume":"14","author":"Ai","year":"2020","journal-title":"Drug Des Dev Ther"},{"key":"B75","doi-asserted-by":"publisher","first-page":"116335","DOI":"10.1016\/j.lfs.2019.03.040","article-title":"LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195","volume":"231","author":"Wang","year":"2019","journal-title":"Life Sci"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28884","article-title":"Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p","volume":"234","author":"Zhou","year":"2019","journal-title":"J Cell Physiol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2018.2698","article-title":"LncRNA KB-1471A8.2 overexpression suppresses cell proliferation and migration and antagonizes the paclitaxel resistance of ovarian cancer cells","volume":"34","author":"Zhang","year":"2019","journal-title":"Cancer Biotherapy Radiopharm"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24563","article-title":"Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans","volume":"54","author":"Yang","year":"2011","journal-title":"Hepatology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-019-00718-w","article-title":"LncRNA HEIH enhances paclitaxel-tolerance of endometrial cancer cells via activation of MAPK signaling pathway","volume":"26","author":"Guo","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s147586","article-title":"LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194","volume":"10","author":"An","year":"2017","journal-title":"OncoTargets Ther"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s222703","article-title":"Long noncoding RNA HCP5 regulates pancreatic cancer gemcitabine (GEM) resistance by sponging hsa-miR-214-3p to target HDGF","volume":"12","author":"Liu","year":"2019","journal-title":"OncoTargets Ther"},{"key":"B82","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13046-019-1055-9","article-title":"Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression","volume":"38","author":"Shi","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.32604\/or.2024.044547","article-title":"LncRNA AFAP1-AS1 exhibits oncogenic characteristics and promotes gemcitabine-resistance of cervical cancer cells through miR-7-5p\/EGFR axis","volume":"32","author":"Wang","year":"2024","journal-title":"Oncol Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/jog.15245","article-title":"lncRNA DLG1-AS1 promotes cervical cancer cell gemcitabine resistance by regulating miR-16-5p\/HDGF","volume":"48","author":"Zou","year":"2022","journal-title":"J Obstet Gynaecol Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1159\/000493625","article-title":"lncRNA DLG1-AS1 promotes cell proliferation by competitively binding with miR-107 and up-regulating ZHX1 expression in cervical cancer","volume":"49","author":"Rui","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/cbm-182383","article-title":"Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer","volume":"25","author":"Lampropoulou","year":"2019","journal-title":"Cancer biomark"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10588","article-title":"The identification of CRNDE, H19, UCA1 and HOTAIR as the key lncRNAs involved in oxaliplatin or irinotecan resistance in the chemotherapy of colorectal cancer based on integrative bioinformatics analysis","volume":"20","author":"Sun","year":"2019","journal-title":"Mol Med Rep"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2014.2758","article-title":"Long non-coding RNA HOTAIR is associated with human cervical cancer progression","volume":"46","author":"Kim","year":"2014","journal-title":"Int J Oncol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000519844","article-title":"LncRNA HOTAIR Promotes Chemoresistance by Facilitating Epithelial to Mesenchymal Transition through miR-29b\/PTEN\/PI3K Signaling in Cervical Cancer","volume":"211","author":"Zhang","year":"2022","journal-title":"Cells Tissues Organs"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acc.2019.12.004","article-title":"Chapter Four Long non-coding RNA HOTAIR in cervical cancer: Molecular marker, mechanistic insight, and therapeutic target","volume":"97","author":"Zhou","year":"2020","journal-title":"Adv Clin Chem"},{"key":"B91","doi-asserted-by":"publisher","first-page":"BSR20200533","DOI":"10.1042\/bsr20200533","article-title":"Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a\/LDHA axis","volume":"41","author":"Shao","year":"2021","journal-title":"Biosci Rep"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202004_20816","article-title":"LncRNA UCA1 regulates proliferation, migration and invasion of cervical cancer cells by targeting miR-145","volume":"24","author":"Wei","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/s41598-020-60143-x","article-title":"MiR-23b-3p reduces the proliferation, migration and invasion of cervical cancer cell lines via the reduction of c-Met expression","volume":"10","author":"Campos-Viguri","year":"2020","journal-title":"Sci Rep"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s258727","article-title":"lncRNA UCA1 contributes to 5-fluorouracil resistance of colorectal cancer cells through miR-23b-3p\/ZNF281 axis","volume":"13","author":"Xian","year":"2020","journal-title":"OncoTargets Ther"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1186\/s12860-019-0188-1","article-title":"Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells","volume":"20","author":"Yang","year":"2019","journal-title":"BMC Mol Cell Biol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e000462","DOI":"10.1136\/esmoopen-2018-000462","article-title":"Targeted therapy in cervical cancer","volume":"3","author":"Vora","year":"2018","journal-title":"ESMO Open"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204078","article-title":"LncRNA CRART16\/miR-122-5p\/FOS axis promotes angiogenesis of gastric cancer by upregulating VEGFD expression","volume":"14","author":"Zhang","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1097\/cad.0000000000001289","article-title":"LncRNA SNHG11 enhances bevacizumab resistance in colorectal cancer by mediating miR-1207-5p\/ABCC1 axis","volume":"33","author":"Huang","year":"2022","journal-title":"Anti-Cancer Drugs"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2021.02.130","article-title":"LncRNA MITA1 promotes gefitinib resistance by inducing autophagy in lung cancer cells","volume":"551","author":"Hu","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B100","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s41419-020-03047-y","article-title":"Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00656","article-title":"LncRNA UCA1 induces acquired resistance to gefitinib by epigenetically silencing CDKN1A expression in non-small-cell lung cancer","volume":"10","author":"Xu","year":"2020","journal-title":"Front Oncol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202010_23197","article-title":"LncRNA UCA1 regulates cervical cancer survival and EMT occurrence by targeting miR-155","volume":"24","author":"Yang","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201911_19560","article-title":"LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621","volume":"23","author":"Chen","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2020.01.006","article-title":"lncRNA CCAT1 acts as a microRNA-218 sponge to increase gefitinib resistance in NSCLC by targeting HOXA1","volume":"19","author":"Jin","year":"2020","journal-title":"Mol Ther - Nucleic Acids"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201903_17384","article-title":"The expression and significance of lncRNA HOST2 and microRNA let-7b in HPV-positive cervical cancer tissues and cell lines","volume":"23","author":"Zhang","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2019.1609829","article-title":"Long non-coding RNA CCAT1 promotes cervical cancer cell proliferation and invasion by regulating the miR-181a-5p\/MMP14 axis","volume":"18","author":"Shen","year":"2019","journal-title":"Cell Cycle"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8413","article-title":"Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00025","article-title":"LncRNAs GIHCG and SPINT1-AS1 are crucial factors for pan-cancer cells sensitivity to lapatinib","volume":"10","author":"Xiang","year":"2019","journal-title":"Front Genet"},{"key":"B109","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12935-020-01419-0","article-title":"LncRNA HOTAIR induces sunitinib resistance in renal cancer by acting as a competing endogenous RNA to regulate autophagy of renal cells","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.03.004","article-title":"Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA","volume":"29","author":"Qu","year":"2016","journal-title":"Cancer Cell"},{"key":"B111","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.canlet.2021.08.028","article-title":"Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR\/ER\u03b2\/Hif2-\u03b1 signaling","volume":"524","author":"He","year":"2022","journal-title":"Cancer Lett"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2014.10.008","article-title":"The role of signaling pathways in cervical cancer and molecular therapeutic targets","volume":"45","author":"Manzo-Merino","year":"2014","journal-title":"Arch Med Res"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-17-1355","article-title":"ERK inhibition: A new front in the war against MAPK pathway\u2013driven cancers","volume":"8","author":"Smalley","year":"2018","journal-title":"Cancer Discov"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073464","article-title":"PI3K inhibitors in cancer: clinical implications and adverse effects","volume":"22","author":"Mishra","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B115","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40659-020-00301-7","article-title":"\u03b2-Catenin: oncogenic role and therapeutic target in cervical cancer","volume":"53","author":"Wang","year":"2020","journal-title":"Biol Res"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.729228","article-title":"Inhibition of wnt-\u03b2-catenin signaling by ICRT14 drug depends of post-transcriptional regulation by HOTAIR in human cervical cancer heLa cells","volume":"11","author":"Trujano-Camacho","year":"2021","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1644104\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:13:13Z","timestamp":1761019993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1644104\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":116,"alternative-id":["10.3389\/fonc.2025.1644104"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1644104","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"article-number":"1644104"}}